Phase 2 Diabetic Kidney Disease Clinical Trials
10 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–10 of 10 trials
Recruiting
Phase 2
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
Diabetic Kidney Disease (DKD)
Regeneron Pharmaceuticals270 enrolled47 locationsNCT07271186
Recruiting
Phase 2
NAD Augmentation in Diabetes Kidney Disease
Type2diabetesDiabetic Kidney Disease
Brigham and Women's Hospital156 enrolled1 locationNCT05759468
Recruiting
Phase 2
The Evaluation of the Drug R3R01 for the Excretion of Protein in the Urine in Patients With Diabetic Kidney Disease.
Diabetic Kidney Disease
River 3 Renal Corp.60 enrolled1 locationNCT06600412
Recruiting
Phase 2
Safety and Efficacy of Mesenchymal Stromal Cells (Amimestrocel ) in Diabetic Kidney Disease
Diabetic Kidney Disease (DKD)
Chinese PLA General Hospital120 enrolled6 locationsNCT06969807
Recruiting
Phase 2
Formoterol in Diabetes
Diabetic Kidney DiseaseDiabetic Nephropathies
Medical University of South Carolina120 enrolled1 locationNCT07022418
Recruiting
Phase 2
Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
Type 1 DiabetesDiabetic Kidney Disease
University of Washington60 enrolled4 locationsNCT05822609
Recruiting
Phase 2
Renal Mechanism of SGLT2 Inhibition
Type 2 DiabetesDiabetic Kidney Disease
University of Colorado, Denver40 enrolled2 locationsNCT05507892
Recruiting
Phase 2
Efficacy and Safety Study of Isuzinaxib in Subjects With DKD
Diabetic Kidney Disease (DKD)
Aptabio Therapeutics, Inc.186 enrolled20 locationsNCT06962098
Recruiting
Phase 2Phase 3
Clinical Outcome of Vinpocetine in Diabetic Nephropathy
Diabetic Kidney DiseaseDiabetic Nephropathies
Ain Shams University64 enrolled2 locationsNCT06441591
Completed
Phase 2
Study to assess the safety and effectiveness of propagermanium as add-on therapy in Diabetic Kidney Disease (DKD) patients who are already taking Irbesartan
Diabetic Kidney Disease (DKD)
Dimerix Ltd40 enrolled14 locationsACTRN12618000982213